University of Calgary
Calgary, Alberta, Canada
35 recruiting
Showing 1–20 of 113 trials
Recruiting
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
Primary Biliary Cholangitis
Ipsen424 enrolled68 locationsNCT06447168
Recruiting
Not Applicable
ELEVATE-HFpEF Clinical Study
Heart Failure With Preserved Ejection Fraction (HFpEF)
Medtronic Cardiac Rhythm and Heart Failure700 enrolled46 locationsNCT06678841
Recruiting
Phase 2
Cannabidiol Medication Intervention Trial
Alzheimer Disease
Sunnybrook Health Sciences Centre40 enrolled5 locationsNCT06014424
Recruiting
Phase 2
A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
Myotonic Dystrophy 1
PepGen Inc24 enrolled8 locationsNCT06667453
Recruiting
Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Bronchiectasis
Boehringer Ingelheim1,755 enrolled470 locationsNCT06872892
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled292 locationsNCT07207811
Recruiting
Not Applicable
Evaluation of A Clinical Diagnostic Test for CRDS
Calcium Release Deficiency Syndrome (CRDS)
Population Health Research Institute400 enrolled20 locationsNCT06188689
Recruiting
Phase 3
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Primary Biliary Cholangitis
Gilead Sciences318 enrolled205 locationsNCT06051617
Recruiting
Phase 3
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Heart FailureObesity
Novo Nordisk A/S5,610 enrolled839 locationsNCT07567001
Recruiting
Not Applicable
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Colorectal, CancerColorectal NeoplasmsColorectal Polyp+2 more
Dartmouth-Hitchcock Medical Center8,946 enrolled22 locationsNCT05612347
Recruiting
An Innovative Master Platform for Clinical Trials in Mood Disorders
Depressive DisorderMood DisordersBipolar and Related Disorders
St. Joseph's Healthcare Hamilton2,200 enrolled9 locationsNCT06408012
Recruiting
Predictors of Relapse in Major Depressive Disorder (PERFORM-D)
Major Depressive Disorder (MDD)
Abraham Nunes252 enrolled9 locationsNCT06746155
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled525 locationsNCT06632444
Recruiting
Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Disease (IBD)+1 more
TIDHI Innovation Inc.200 enrolled12 locationsNCT07245394
Recruiting
Cohort Network for Adolescents and Youth With multipLe Mental Health Conditions
Child Mental HealthMultiple Mental Health ConditionsYouth mental health
Centre for Addiction and Mental Health1,620 enrolled6 locationsNCT07699159
Recruiting
Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
Metabolic Dysfunction-Associated Steatohepatitis
Boehringer Ingelheim1,590 enrolled444 locationsNCT06632457
Recruiting
Phase 3
ACT-GLOBAL Adaptive Platform Trial for Stroke
Stroke
The George Institute20,000 enrolled2 locationsNCT06352632
Recruiting
Not Applicable
Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial
Ischemic Stroke, Acute
The George Institute2,000 enrolled2 locationsNCT06352619
Recruiting
Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Diabetes Mellitus, Type 1
Novo Nordisk A/S877 enrolled196 locationsNCT07076199
Recruiting
Phase 3
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company587 enrolled103 locationsNCT06563895